NOS3 rs1799971: Understanding Your Genetic Variant
The rs1799971 variant is a genetic change located within the NOS3 gene, which is responsible for producing the enzyme endothelial nitric oxide synthase. This variant is studied for its potential influence on nitric oxide production, a molecule critical for maintaining healthy blood pressure and vascular function.
What each genotype means
Typical nitric oxide production
This genotype represents the common version of the NOS3 gene, often referred to as the Glu298 allele. Research suggests this version is associated with standard endothelial nitric oxide synthase function, though individual cardiovascular risk is influenced by many genetic and lifestyle factors.
This is the most common genotype in many global populations, though its frequency varies significantly by ancestry.
Altered nitric oxide potential
This heterozygous genotype contains one copy of the Glu298 allele and one copy of the Asp298 allele. Some studies suggest this variation may influence nitric oxide production and cardiovascular health, though findings are mixed and often depend on specific environmental or clinical contexts.
This genotype is frequently observed, with the Asp298 allele being particularly common in populations of European ancestry.
Variant nitric oxide potential
This genotype consists of two copies of the Asp298 allele. While some research has explored its association with altered nitric oxide production and potential susceptibility to cardiovascular conditions, the clinical significance remains a subject of ongoing study and debate. You should discuss your overall cardiovascular health and any concerns with your clinician.
This genotype is less common than the heterozygous form and shows marked interethnic differences, being more prevalent in Caucasian populations compared to African American or Asian populations.
What is the rs1799971 Variant?
The rs1799971 variant is a single nucleotide polymorphism (SNP) located within the NOS3 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in a region of the genome that influences the expression or function of the NOS3 gene. Because DNA is inherited in pairs—one set from each parent—individuals can carry different combinations of the nucleotides at this position. Researchers track these variations to understand how subtle differences in our genetic code might contribute to biological diversity and, in some cases, differences in susceptibility to common health conditions. It is important to note that the presence of a specific variant does not determine a health outcome on its own, as most complex traits are influenced by a combination of many genetic factors, environmental exposures, and lifestyle choices.
The Role of the NOS3 Gene
The NOS3 gene provides instructions for making an enzyme called endothelial nitric oxide synthase (eNOS). This enzyme is primarily found in the cells that line the inside of blood vessels, known as endothelial cells. Its main job is to produce nitric oxide, a signaling molecule that plays a vital role in cardiovascular health. Nitric oxide acts as a vasodilator, meaning it helps relax and widen blood vessels, which allows blood to flow more easily and helps maintain healthy blood pressure levels. When the production of nitric oxide is impaired or altered, it can affect how blood vessels respond to stress or changes in demand. Because of its central role in vascular tone, researchers have long investigated how variations in the NOS3 gene might influence the efficiency of this process and whether such variations are linked to conditions like hypertension or other cardiovascular issues.
Research and Evidence Strength
Scientific research into the NOS3 gene has identified several variants, including rs1799971, that are frequently studied in the context of cardiovascular health. Studies have explored whether these variants correlate with differences in blood pressure or the risk of developing coronary artery disease. While some meta-analyses have suggested statistical associations between certain NOS3 variants and cardiovascular outcomes, the evidence is often described as moderate. This means that while a correlation may be observed in large population studies, the effect size of any single variant is typically small. Furthermore, results can be inconsistent across different studies, likely due to differences in study design, the populations being analyzed, and the influence of other genetic or environmental factors. It is essential to view these findings as statistical observations rather than definitive predictors of individual health, as the biological impact of this variant remains a subject of ongoing scientific investigation.
Population Frequency
The frequency of the rs1799971 variant is not uniform across the globe. Genetic studies show that the prevalence of specific alleles at this position varies significantly depending on an individual's ancestral background. In many global populations, the minor allele frequency—the frequency at which the less common version of the variant occurs—generally ranges between 0.3 and 0.4. This variation is a normal part of human genetic diversity. Because frequency patterns are tied to ancestry, it is common for researchers to observe different distributions of these genotypes when comparing diverse groups. Understanding these frequency differences is a key part of population genetics, as it helps scientists account for ancestral background when conducting studies to ensure that findings are interpreted accurately within the context of the population being examined.
Interpreting Your Genetic Information
If you have received information about your genotype for rs1799971, it is important to understand what this means in a practical sense. Genetic variants are only one piece of a much larger puzzle that includes your diet, physical activity, stress levels, and overall medical history. You cannot use this information to diagnose yourself with a condition or to predict a specific health outcome. If you are concerned about your cardiovascular health, blood pressure, or how your genetics might influence your response to medications, the most appropriate step is to consult with a qualified healthcare professional or a pharmacist. They can provide personalized guidance based on your full clinical picture, rather than relying on a single genetic marker. Avoid making changes to your health regimen based solely on genetic reports without professional medical oversight.
How common is this variant?
The minor allele frequency for rs1799971 varies significantly by ancestry, generally ranging from 0.3 to 0.4 in global populations.
Frequently asked questions
Does the rs1799971 variant cause heart disease?
No, this variant does not cause heart disease. It is a genetic marker that has been studied for its potential association with cardiovascular health, but it is not a direct cause of disease.
Can I use this SNP to predict my blood pressure?
No, you cannot use this SNP to predict your blood pressure. Blood pressure is a complex trait influenced by many genes, environmental factors, and lifestyle habits, not just a single genetic variant.
Should I change my diet based on my NOS3 genotype?
You should not change your diet based on this genotype alone. Always consult with a doctor or a registered dietitian before making significant changes to your diet, especially if you have concerns about cardiovascular health.
Is this variant the same as the Glu298Asp variant?
The Glu298Asp variant is a well-known polymorphism in the NOS3 gene, often referred to by the rs1799983 identifier. While rs1799971 is also in the NOS3 gene, they are distinct genetic markers.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799971?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Promoter variant (-786T>C) in the NOS3 gene associated with endothelial nitric oxide synthase expression and cardiovascular risk.
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
An intronic endothelial nitric oxide synthase polymorphism that influences vascular tone, exercise-induced vasodilation, and aerobic endurance performance.
Commonly studied variant in the endothelial nitric oxide synthase gene, associated with cardiovascular traits.
Endothelial nitric oxide synthase variant implicated in blood flow response and muscle capillarization during aerobic training.
Promoter-adjacent polymorphism affecting endothelial nitric oxide synthase transcription, modulating exercise-induced vasodilation and aerobic trainability.